Manning & Napier Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$17.7M Sell
258,118
-41,457
-14% -$2.67M 0.2% 93
2023
Q4
$17.3M Sell
299,575
-1,277
-0.4% -$68.2K 0.21% 96
2023
Q3
$15.9M Sell
300,852
-162,021
-35% -$8.5M 0.2% 104
2023
Q2
$25M Sell
462,873
-5,326
-1% -$278K 0.29% 86
2023
Q1
$23.4M Buy
468,199
+102,028
+28% +$4.81M 0.27% 86
2022
Q4
$16.9M Sell
366,171
-39,647
-10% -$1.72M 0.21% 110
2022
Q3
$15.7M Sell
405,818
-579
-0.1% -$23.2K 0.21% 113
2022
Q2
$15.1M Sell
406,397
-25,186
-6% -$1.03M 0.17% 116
2022
Q1
$19.1M Sell
431,583
-12,000
-3% -$520K 0.18% 117
2021
Q4
$18.8M Sell
443,583
-880
-0.2% -$37K 0.16% 125
2021
Q3
$19.3M Sell
444,463
-2,205
-0.5% -$97.6K 0.17% 118
2021
Q2
$19.1M Sell
446,668
-13,931
-3% -$586K 0.16% 127
2021
Q1
$17.8M Buy
460,599
+31,853
+7% +$1.21M 0.15% 136
2020
Q4
$15.4M Buy
428,746
+44,862
+12% +$1.62M 0.14% 136
2020
Q3
$14.7M Sell
383,884
-5,641
-1% -$217K 0.15% 122
2020
Q2
$13.7M Buy
389,525
+15,369
+4% +$553K 0.15% 125
2020
Q1
$12.2M Sell
374,156
-121,225
-24% -$4.74M 0.14% 117
2019
Q4
$22.4M Sell
495,381
-40,095
-7% -$1.68M 0.24% 96
2019
Q3
$21.8M Sell
535,476
-70,410
-12% -$2.98M 0.24% 99
2019
Q2
$26M Buy
+605,886
New +$23.3M 0.28% 90

Other funds holding BSX

Manning & Napier Group's BSX Position: Q1 2024 in Review

Manning & Napier Group reduced its Boston Scientific (BSX) stake by 14% in Q1 2024, selling an estimated $2.67M and leaving 258,118 shares worth $17.7M. The position accounts for 0.2% of the portfolio, ranked #93.

Manning & Napier Group first reported a position in BSX in Q2 2019 and has held it in 20 quarters since. The position peaked at $26M in Q2 2019. 1,227 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Manning & Napier Group held 258,118 shares of Boston Scientific worth $17.7M as of Q1 2024.
  • Manning & Napier Group sold 41,457 Boston Scientific shares in Q1 2024, an estimated $2.67M.
  • Boston Scientific made up 0.2% of Manning & Napier Group's portfolio in Q1 2024, its #93 holding.
  • Manning & Napier Group first reported a position in Boston Scientific in Q2 2019 and has held it in 20 quarters since.
  • Manning & Napier Group's Boston Scientific position peaked at $26M in Q2 2019.
  • 1,227 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.